Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7494 p329
22 March 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Test speeds up TB diagnosis

A new T-cell-based interferon-g release assay can rule out tuberculosis infection within days rather than weeks and has 99 per cent sensitivity when used in combination with tuberculin skin testing (Annals of Internal Medicine 2008;148:325).

UK researchers tested the ELISpot-Plus assay in diagnosing 389 patients with suspected active TB. The test can distinguish TB infection from BCG vaccination because it incorporates a novel antigen — Rv3879c — that reacts with T cells induced by infection.

Back to Top


©The Pharmaceutical Journal